Aldeyra Therapeutics (ALDX) Notes Payables (2013 - 2014)
Aldeyra Therapeutics (ALDX) posted Notes Payables of $155097.0 for Q1 2014, up 82.47% on a QoQ basis from $85000.0 in Q4 2013.
Aldeyra Therapeutics (ALDX) Notes Payables (2013 - 2014) Analysis & Trends
Aldeyra Therapeutics' Notes Payables history runs 2 years deep, the most recent figure standing at $155097.0 for Q1 2014.
- Quarterly Notes Payables changed N/A year-over-year to $155097.0 in Q1 2014, while the trailing twelve-month figure through Mar 2014 was $155097.0 (changed N/A YoY) and the FY2013 annual result came in at $85000.0, changed N/A from the prior year.
- Notes Payables was $155097.0 for Q1 2014 at Aldeyra Therapeutics, up from $85000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $155097.0 in Q1 2014 and bottomed at $85000.0 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Aldeyra Therapeutics | 95.00 Mn | 95.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 155,097.00 |
| Dec 31, 2013 | 85,000.00 |